A 42% of patients with heart failure have depression symptoms, a common co-morbidity linked to poor quality of life and a bad prognosis. In addition to having an adverse effect on everyday social and domestic activities, 1-3 depressive symptoms significantly…
The pathophysiology of cardiovascular disease and protein-energy wasting, which are significant risk factors for morbidity and mortality in individuals with end-stage kidney disease, are linked to inflammation. Anti-cytokine therapy has been proposed to reduce inflammation and improve outcomes. Anakinra’s effectiveness,…
The immediate reason for death in patients today with severe respiratory distress brought on by COVID-19 is cytokine syndromes. Given that cytokine storms can be fatal, it’s crucial to treat patients with the proper medications, Anakinra, based on their particular…
